Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Cost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Select Medical Holdings (SEM) Equity Income: 2010-2024

Historic Equity Income for Select Medical Holdings (SEM) over the last 15 years, with FY2024 value amounting to $60.2 million.

  • Select Medical Holdings' Equity Income fell 6071.24% to $13.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $51.6 million, marking a year-over-year decrease of 799.36%. This contributed to the annual value of $60.2 million for FY2024, which is 4757.06% up from last year.
  • Select Medical Holdings' Equity Income amounted to $60.2 million in FY2024, which was up 4757.06% from $40.8 million recorded in FY2023.
  • In the past 5 years, Select Medical Holdings' Equity Income registered a high of $60.2 million during FY2024, and its lowest value of $26.4 million during FY2022.
  • In the last 5 years, Select Medical Holdings' Equity Income had a median value of $40.8 million in 2023 and averaged $40.3 million.
  • In the last 5 years, Select Medical Holdings' Equity Income crashed by 4056.23% in 2022 and then surged by 5455.37% in 2023.
  • Select Medical Holdings' Equity Income (Annual) stood at $29.4 million in 2020, then soared by 50.91% to $44.4 million in 2021, then tumbled by 40.56% to $26.4 million in 2022, then surged by 54.55% to $40.8 million in 2023, then soared by 47.57% to $60.2 million in 2024.
  • Its Equity Income stands at $60.2 million for FY2024, versus $40.8 million for FY2023 and $26.4 million for FY2022.